Obesity and Prostate Cancer: Weighing the Evidence
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Context Obesity and prostate cancer (PCa) affect substantial proportions of Western society. Mounting evidence, both epidemiologic and mechanistic, for an association between the two is of public health interest. An improved understanding of the role of this modifiable risk factor in PCa etiology is imperative to optimize screening, treatment, and prevention. Objective To consolidate and evaluate the evidence for an epidemiologic link between obesity and PCa, in addition to examining the proposed underlying molecular mechanisms. Evidence acquisition A PubMed search for relevant articles published between 1991 and July 2012 was performed by combining the following terms: obesity, BMI, body mass index and prostate cancer risk, prostate cancer incidence, prostate cancer mortality, radical prostatectomy, androgen-deprivation therapy, external-beam radiation, brachytherapy, prostate cancer and quality of life, prostate cancer and active surveillance, in addition to obesity, BMI, body mass index and prostate cancer and insulin, insulinlike growth factor, androgen, estradiol, leptin, adiponectin, and IL-6. Articles were selected based on content, date of publication, and relevancy, and their references were also searched for relevant articles. Evidence synthesis Increasing evidence suggests obesity is associated with elevated incidence of aggressive PCa, increased risk of biochemical failure following radical prostatectomy and external-beam radiotherapy, higher frequency of complications following androgen-deprivation therapy, and increased PCa-specific mortality, although perhaps a lower overall PCa incidence. These results may in part relate to difficulties in detecting and treating obese men. However, multiple molecular mechanisms could explain these associations as well. Weight loss slows PCa in animal models but has yet to be fully tested in human trials. Conclusions Obesity appears to be linked with aggressive PCa. We suggest clinical tips to better diagnose and treat obese men with PCa. Whether reversing obesity slows PCa growth is currently unknown, although it is an active area of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Multiple large cohort studies have consistently demonstrated a positive dose–response relationship between increasing BMI and fatal PCa [2,13,17].”
BackgroundPrevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“These trends have stabilized in the past 10 yr [5], suggesting these levels are established as a permanent feature of US society.”
BackgroundRenehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
International Variation in Prostate Cancer Incidence and Mortality Rates
Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., & Bray, F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.054 · Cited by 1,521 · cited 1×
“Prostate cancer (PCa) is the second most commonly diagnosed cancer and the sixth most common cause of cancer-related mortality among men worldwide [1].”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 1×
“013 last decade, multiple epidemiologic studies have suggested that obesity is associated with increased risk and death from numerous cancer types including PCa [2–4].”
BackgroundMetformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Overweight as an avoidable cause of cancer in Europe
Bergström, A., Pisani, P., Tenet, V., Wolk, A., & Adami, H. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t · Cited by 758
Obesity prevalence from a European perspective: a systematic review
Berghöfer, A., Pischon, T., Reinhold, T., Apovian, C. M., Sharma, A. M., & Willich, S. N. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-200 · Cited by 730
Biological Mechanisms Linking Obesity and Cancer Risk: New Perspectives
Roberts, D. L., Dive, C., & Renehan, A. G. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.080708.082713 · Cited by 610
Kenfield, S. A., Stampfer, M. J., Giovannucci, E., & Chan, J. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5226 · Cited by 601
Cao, Y., & Ma, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0229 · Cited by 485
Il'yasova, D., Colbert, L. H., Harris, T. B., Newman, A. B., Bauer, D. C., Satterfield, S., & Kritchevsky, S. B. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0316 · Cited by 479 · cited 1×
“Large prospective cohort studies are required to test this, but to date, only three small prospective studies have examined the association of IL-6 and PCa; two reported no association [11,76], and the third reported a modest inverse association between IL-6 and PCa risk [77].”
BackgroundHobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G. C., Klocker, H., & Čulig, Z. (1998) · PubMed · Cited by 437
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421 · cited 1×
“A large prospective survival analysis reported that higher serum C-peptide concentrations, a surrogate of insulin levels, were associated with increased PCa-specific mortality [49].”
BackgroundBody size and composition and prostate cancer risk: systematic review and meta-regression analysis
MacInnis, R. J., & English, D. R. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0049-z · Cited by 411
Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction Workers
Andersson, S.-O., Wolk, A., Bergstrom, R., Adami, H.-O., Engholm, G., Englund, A., & Nyren, O. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.385 · Cited by 406
Michalaki, V, Syrigos, K., Charles, P., & Waxman, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601814 · Cited by 406
Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer
Bañez, L. L., Hamilton, R. J., Partin, A. W., Vollmer, R. T., Sun, L., Rodriguez, C., Wang, Y., Terris, M. K., Aronson, W. J., Presti, J. C., et al. (2007) · JAMA · doi:10.1001/jama.298.19.2275 · Cited by 357
Self-citationRodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Self-citationRodríguez, C., Patel, A. V., Calle, E. E., Jacobs, E. J., Chao, A., & Thun, M. J. (2001) · PubMed · Cited by 354
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Gong, Z., Neuhouser, M. L., Goodman, P. J., Albanes, D., Chi, C., Hsing, A. W., Lippman, S. M., Platz, E. A., Pollak, M. N., Thompson, I. M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0477 · Cited by 352
Wright, M. E., Chang, S., Schatzkin, A., Albanes, D., Kipnis, V., Mouw, T., Hurwitz, P., Hollenbeck, A., & Leitzmann, M. F. (2007) · Cancer · doi:10.1002/cncr.22443 · Cited by 336
Okamoto, M., Lee, C., & Oyasu, R. (1997) · PubMed · Cited by 304
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
Prostate cancer and adiponectin
Goktas, S., Yilmaz, M. I., Caglar, K., Sonmez, A., Kilic, S., & Bedir, S. (2005) · Urology · doi:10.1016/j.urology.2004.12.053 · Cited by 288
Obesity, Recreational Physical Activity, and Risk of Pancreatic Cancer In a Large U.S. Cohort
Patel, A. V., Rodriguez, C., Bernstein, L., Chao, A., Thun, M. J., & Calle, E. E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0583 · Cited by 286
Discacciati, A., Orsini, N., & Wolk, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr603 · Cited by 278
Wright, J. L., & Stanford, J. L. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9407-y · Cited by 276
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., Hamdy, F., Stephens, P., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272
Shariat, S. F., Andrews, B., Kattan, M. W., Kim, J., Wheeler, T. M., & Slawin, K. M. (2001) · Urology · doi:10.1016/s0090-4295(01)01405-4 · Cited by 261 · cited 1×
“Circulating IL-6 levels are elevated in PCa patients with metastatic relative to organ-confined disease [73,74], and they are associated with time to progression to metastatic disease [75].”
BackgroundNickerson, T., Chang, F., Lorimer, D., Smeekens, S. P., Sawyers, C. L., & Pollak, M. (2001) · PubMed · Cited by 258
Rowlands, M., Gunnell, D., Harris, R., Vatten, L. J., Holly, J. M. P., & Martin, R. M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24202 · Cited by 251
The association of body mass index and prostate‐specific antigen in a population‐based study
Baillargeon, J., Pollock, B. H., Kristal, A. R., Bradshaw, P., Hernandez, J., Basler, J., Higgins, B., Lynch, S., Rozanski, T., Troyer, D., et al. (2005) · Cancer · doi:10.1002/cncr.20856 · Cited by 251
Obesity and Prostate Cancer: Epidemiology and Clinical Implications
Buschemeyer, W. C., & Freedland, S. J. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.069 · Cited by 251
Self-citationTestosterone and Prostate Cancer: An Historical Perspective on a Modern Myth
Morgentaler, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.034 · Cited by 247
Does Physical Activity Reduce the Risk of Prostate Cancer? A Systematic Review and Meta-analysis
Liu, Y., Hu, F., Li, D., Wang, F., Zhu, L., Chen, W., Ge, J., An, R., & Zhao, Y. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.007 · Cited by 231
Insulin receptor expression by human prostate cancers
Cox, M. E., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O., Fazli, L., & Pollak, M. (2009) · The Prostate · doi:10.1002/pros.20852 · Cited by 223
Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
Engeland, A., Tretli, S., & Bjørge, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601206 · Cited by 217
Fizazi, K., De Bono, J. S., Flechon, A., Heidenreich, A., Voog, E., Davis, N. B., Qi, M., Bandekar, R., Vermeulen, J. T., Cornfeld, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.014 · Cited by 197
Bonkhoff, H., & Berges, R. (2009) · European Urology · doi:10.1016/j.eururo.2008.10.035 · Cited by 185
Freedland, S. J., Platz, E. A., Presti, J. C., Aronson, W. J., Amling, C. L., Kane, C. J., & Terris, M. K. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00162-x · Cited by 183
Self-citationVenkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H., & Pollak, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm231 · Cited by 182
Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
Kasper, J. S., Liu, Y., & Giovannucci, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24044 · Cited by 180
Prostate cancer cell proliferation is influenced by leptin1
Somasundar, P. S., Frankenberry, K. A., Skinner, H. D., Vedula, G., McFadden, D. W., Riggs, D. R., Jackson, B., VanGilder, R. L., Hileman, S. M., & Vona-Davis, L. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.01.017 · Cited by 171
Estrogen and prostate cancer: An eclipsed truth in an androgen‐dominated scenario
Carruba, G. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21529 · Cited by 170
Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis
Freedland, S. J., Mavropoulos, J., Wang, A., Darshan, M., Demark‐Wahnefried, W., Aronson, W. J., Cohen, P., Hwang, D., Peterson, B., Fields, T., et al. (2008) · The Prostate · doi:10.1002/pros.20683 · Cited by 169
Self-citationLi, H., Stampfer, M. J., Mucci, L. A., Rifai, N., Qiu, W., Kurth, T., & Ma, J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.133272 · Cited by 160
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
Theoret, M. R., Ning, Y. M., Zhang, J. J., Justice, R. L., Keegan, P., & Pazdur, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106783 · Cited by 158
Periprostatic Adipose Tissue as a Modulator of Prostate Cancer Aggressiveness
Finley, D. S., Calvert, V. S., Inokuchi, J., Lau, A., Narula, N., Petricoin, E. F., Zaldivar, F., Santos, R., Tyson, D. R., & Ornstein, D. K. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.06.015 · Cited by 150
Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer
Jones, L. W., Antonelli, J., Masko, E. M., Broadwater, G., Lascola, C. D., Fels, D., Dewhirst, M. W., Dyck, J. R. B., Nagendran, J., Flores, C. T., et al. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01575.2011 · Cited by 147
Self-citationGrubb, R. L., Black, A., Izmirlian, G., Hickey, T. P., Pinsky, P. F., Mabie, J. E., Riley, T. L., Ragard, L. R., Prorok, P. C., Berg, C. D., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0938 · Cited by 140
Risk of Urinary Incontinence Following Prostatectomy: The Role of Physical Activity and Obesity
Wolin, K. Y., Luly, J. R., Sutcliffe, S. S., Andriole, G. L., & Kibel, A. S. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.09.082 · Cited by 138
Williams, G. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.017 · Cited by 135
Obesity and the risk of prostate cancer
Porter, M. P., & Stanford, J. L. (2004) · The Prostate · doi:10.1002/pros.20121 · Cited by 135
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development
Azevedo, A. S., Cunha, V., Teixeira, A. L., & Medeiros, R. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i12.384 · Cited by 133
Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study
Baillargeon, J., Platz, E. A., Rose, D. P., Pollock, B. H., Ankerst, D. P., Haffner, S., Higgins, B., Lokshin, A., Troyer, D., Hernandez, J., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0082 · Cited by 132
The Relationship Between Nutrition and Prostate Cancer: Is More Always Better?
Masko, E. M., Allott, E. H., & Freedland, S. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.11.012 · Cited by 132
Self-citationRecreational Physical Activity and Risk of Prostate Cancer in a Large Cohort of U.S. Men
Patel, A. V., Rodríguez, C., Jacobs, E. J., Solomon, L., Thun, M. J., & Calle, E. E. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.275.14.1 · Cited by 119
Nilsen, T. I. L., Romundstad, P. R., & Vatten, L. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22184 · Cited by 116
Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
Lubik, A. A., Gunter, J. H., Hendy, S. C., Locke, J. A., Adomat, H. H., Thompson, V., Herington, A., Gleave, M. E., Pollak, M., & Nelson, C. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2470 · Cited by 116
Rider, J. R., Li, H., Kraft, P. L., Kurth, T., Giovannucci, E. L., Stampfer, M. J., Ma, J., & Mucci, L. A. (2008) · International Journal of Cancer · doi:10.1002/ijc.24241 · Cited by 115
Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
van Roermund, J. G. H., Hinnen, K. A., Tolman, C., Bol, G. H., Witjes, J. A., Bosch, J. L. H. R., Kiemeney, L. A. L. M., & van Vulpen, M. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09811.x · Cited by 112
Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
Chun, J. Y., Nadiminty, N., Dutt, S. S., Lou, W., Yang, J. C., Kung, H., Evans, C. P., & Gao, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0640 · Cited by 112
Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue
Ribeiro, R. J. T., Monteiro, C., Catalán, V., Hu, P., Cunha, V. F. P. M., Rodríguez, A., Gómez‐Ambrosi, J., Fraga, A. M., Príncipe, P., Lobato, C., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-108 · Cited by 111
Derweesh, I. H., DiBlasio, C. J., Kincade, M. C., Malcolm, J. B., Lamar, K. D., Patterson, A. L., Kitabchi, A. E., & Wake, R. W. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07184.x · Cited by 104
Keto, C. J., Aronson, W. J., Terris, M. K., Presti, J. C., Kane, C. J., Amling, C. L., & Freedland, S. J. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10754.x · Cited by 100
Self-citationRibeiro, R. J. T., Monteiro, C. P. D., Cunha, V. F. P. M., Azevedo, A. S. M., Oliveira, M. J., Monteiro, R., Fraga, A. M., Príncipe, P., Lobato, C., Lobo, F., et al. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000337604 · Cited by 87
Johnsen, N. F., Tjønneland, A., Thomsen, B. L. R., Christensen, J., Loft, S., Friedenreich, C., Key, T. J., Allen, N. E., Lahmann, P. H., Mejlvig, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24326 · Cited by 86
Weight change and prostate cancer incidence and mortality
Bassett, J. K., Severi, G., Baglietto, L., MacInnis, R. J., Hoang, H. N., Hopper, J. L., English, D. R., & Giles, G. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.27414 · Cited by 86
Joshu, C. E., Mondul, A. M., Menke, A., Meinhold, C. L., Han, M., Humphreys, E. B., Freedland, S. J., Walsh, P. C., & Platz, E. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0257 · Cited by 84
Self-citationDietary Energy Balance Modulates Prostate Cancer Progression in Hi-Myc Mice
Blando, J. M., Moore, T., Hursting, S. D., Jiang, G., Saha, A., Beltrán, L., Shen, J., Repass, J. F., Strom, S. S., & DiGiovanni, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0182 · Cited by 82
Obesity and Sex Steroids during Gonadotropin-Releasing Hormone Agonist Treatment for Prostate Cancer
Smith, M. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2086 · Cited by 77
Bonorden, M. J. L., Rogozina, O. P., Kluczny, C. M., Grossmann, M. E., Grambsch, P. L., Grande, J. P., Perkins, S. N., Lokshin, A. E., & Cleary, M. P. (2009) · Nutrition and Cancer · doi:10.1080/01635580802419798 · Cited by 73
Wong, J. R., Gao, Z., Merrick, S., Wilson, P., Uematsu, M., Woo, K. Y., & Cheng, C.-W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.049 · Cited by 72
Leptin increases motility and integrin up‐regulation in human prostate cancer cells
Huang, C., Yu, H., Lai, T.-Y., Yeh, Y., Su, C., Hsu, H., Tsai, F., Tsai, C., Wu, H., & Tang, C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22455 · Cited by 67
Mitogenic and anti‐apoptotic actions of adipocyte‐derived hormone leptin in prostate cancer cells
Hoda, M. R., & Popken, G. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07534.x · Cited by 64
Rowlands, M., Holly, J. M. P., Gunnell, D., Donovan, J., Lane, J. A., Hamdy, F. C., Neal, D. E., Oliver, S. E., Smith, G. D., & Martin, R. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1601 · Cited by 63
Adipokine genes and prostate cancer risk
Moore, S. C., Leitzmann, M. F., Albanes, D., Weinstein, S. J., Snyder, K., Virtamo, J. R. K., Ahn, J., Mayne, S. T., Yu, H., Peters, U., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24043 · Cited by 60
Yao, S., Till, C., Kristal, A. R., Goodman, P. J., Hsing, A. W., Tangen, C. M., Platz, E. A., Stanczyk, F. Z., Reichardt, J. K. V., Tang, L., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9787-7 · Cited by 55
Prostate cancer gene expression signature of patients with high body mass index
Sharad, S., Srivastava, A., Ravulapalli, S., Parker, P., Chen, Y., Li, H., Petrovics, G., & Dobi, A. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.44 · Cited by 36
Obesity Is Not Predictive of Overall Survival Following Permanent Prostate Brachytherapy
Merrick, G. S., Galbreath, R. W., Butler, W. M., Wallner, K. E., Allen, Z. A., & Adamovich, E. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318068b506 · Cited by 32
Predictive value of digital rectal examination for prostate cancer detection is modified by obesity
Chu, D. I., Nunzio, C. D., Gerber, L., Ja, T., Calloway, E. E., Albisinni, S., Şenocak, Ç., McKeever, M. G., Moreira, D. M., Tubaro, A., et al. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.31 · Cited by 31
Self-citationFreedland, S. J., Haffner, M. C., Landis, P., Saigal, C. S., & Carter, H. B. (2005) · Urology · doi:10.1016/j.urology.2004.12.064 · Cited by 31
Self-citationChamberlain, C., Romundstad, P., VATTEN, L. J., Gunnell, D., & Martin, R. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25739 · Cited by 30
Fesinmeyer, M. D., Gulati, R., Zeliadt, S. B., Weiss, N. S., Kristal, A. R., & Etzioni, R. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0784 · Cited by 29
Montgomery, J. S., Gayed, B. A., Hollenbeck, B. K., Daignault, S. D., Sanda, M. G., Montie, J. E., & Wei, J. T. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(06)00504-0 · Cited by 29
Whitley, B. M., Moreira, D. M., Thomas, J. ‐., Aronson, W. J., Terris, M. K., Presti, J. C., Kane, C. J., Amling, C. L., Freedland, S. J., & the SEARCH Database Study Group (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.42 · Cited by 18
Self-citationImpact of Obesity on Early Erectile Function Recovery after Robotic Radical Prostatectomy
Uffort, E. E., & Jensen, J. C. (2011) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/108680810x12924466009203 · Cited by 17
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
“Leptin, produced in response to lipopolysaccharides, insulin, sex hormones, and pro-inflammatory mediators (IL-1b, IL-6, TNF-α), binds to transmembrane receptors on stomach, colon, estrogen-dependent breast cancer [141], androgen-insensitive prostate [142], and thyroid cells [143], resulting in angiogenesis, cellular…”
BackgroundWang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.811044 · Cited by 646
Gillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., Carver, B., Castellano, D., Chung, B. H., Clarke, N., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.06.002 · Cited by 642
Metadata
- Authors
- Allott, E. H., Masko, E. M., & Freedland, S. J.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 63
- Issue
- 5
- Pages
- 800-809
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2139411934
- Cited by
- 601
- References
- 91
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.